2Centre for Antibiotic Resistance Research, CARe, University of Gothenburg, Gothenburg, Sweden.
1Department of Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Microb Genom. 2018 Nov;4(11). doi: 10.1099/mgen.0.000233. Epub 2018 Nov 21.
Carbapenem resistance is a rapidly growing threat to our ability to treat refractory bacterial infections. To understand how carbapenem resistance is mobilized and spread between pathogens, it is important to study the genetic context of the underlying resistance mechanisms. In this study, the resistomes of six clinical carbapenem-resistant isolates of five different species - Acinetobacter baumannii, Escherichia coli, two Klebsiella pneumoniae, Proteus mirabilis and Pseudomonas aeruginosa - were characterized using whole genome sequencing. All Enterobacteriaceae isolates and the A. baumannii isolate had acquired a large number of antimicrobial resistance genes (7-18 different genes per isolate), including the following encoding carbapenemases: blaKPC-2, blaOXA-48, blaOXA-72, blaNDM-1, blaNDM-7 and blaVIM-1. In addition, a novel version of blaSHV was discovered. Four new resistance plasmids were identified and their fully assembled sequences were verified using optical DNA mapping. Most of the resistance genes were co-localized on these and other plasmids, suggesting a risk for co-selection. In contrast, five out of six carbapenemase genes were present on plasmids with no or few other resistance genes. The expected level of resistance - based on acquired resistance determinants - was concordant with measured levels in most cases. There were, however, several important discrepancies for four of the six isolates concerning multiple classes of antibiotics. In conclusion, our results further elucidate the diversity of carbapenemases, their mechanisms of horizontal transfer and possible patterns of co-selection. The study also emphasizes the difficulty of using whole genome sequencing for antimicrobial susceptibility testing of pathogens with complex genotypes.
碳青霉烯耐药性是对我们治疗耐药细菌感染能力的一个快速增长的威胁。为了了解碳青霉烯耐药性是如何在病原体之间移动和传播的,研究潜在耐药机制的遗传背景非常重要。在这项研究中,使用全基因组测序对来自五个不同种属的 6 株临床碳青霉烯耐药分离株(鲍曼不动杆菌、大肠埃希菌、2 株肺炎克雷伯菌、奇异变形杆菌和铜绿假单胞菌)的耐药组进行了特征描述。所有肠杆菌科分离株和鲍曼不动杆菌分离株都获得了大量的抗菌药物耐药基因(每个分离株 7-18 种不同的基因),包括以下编码碳青霉烯酶的基因:blaKPC-2、blaOXA-48、blaOXA-72、blaNDM-1、blaNDM-7 和 blaVIM-1。此外,还发现了一种新型 blaSHV。鉴定了 4 个新的耐药质粒,并使用光学 DNA 图谱对其全序列进行了验证。大多数耐药基因都位于这些质粒和其他质粒上,提示存在共同选择的风险。相比之下,6 株碳青霉烯酶基因中有 5 株存在于没有或几乎没有其他耐药基因的质粒上。在大多数情况下,基于获得的耐药决定因素预测的耐药水平与测量水平一致。然而,对于 6 株分离株中的 4 株,有 4 种抗生素的多个类别存在重要差异。总之,我们的研究结果进一步阐明了碳青霉烯酶的多样性、它们的水平转移机制以及可能的共同选择模式。该研究还强调了使用全基因组测序来检测具有复杂基因型的病原体的抗菌药物敏感性的困难。